Sirolimus and Staged OK ‐432 Sclerotherapy for Airway‐Compromising Cervicofacial Lymphatic Malformation in a Neonate
Pediatrics International · 2026-01 · 68 (1)
DOI: 10.1111/ped.70529 ↗At a glance
Journal article in Pediatrics International, published online on 2026-08-20. Written by Keiji Tasaka and 6 co-authors. Institution: Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan. 5 references. The full text is freely available in PubMed Central.
Abstract (original language)
Ebda abstract disponibbli.
Subjects
Author keywords
Authors and institutions
- Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
- Department of Neonatology, Shizuoka Children's Hospital, Shizuoka, Japan.
- Department of Pediatric Surgery, Shizuoka Children's Hospital, Shizuoka, Japan.
ORCID profiles: Keiji Tasaka, Koji Kawaguchi, Yousuke Gohda, Kenichiro Watanabe
Cite
APA
Tasaka, K., Kawaguchi, K., Hirose, A., Gohda, Y., Nakano, R., Fukumoto, K., & Watanabe, K. (2026). Sirolimus and Staged OK ‐432 Sclerotherapy for Airway‐Compromising Cervicofacial Lymphatic Malformation in a Neonate. Pediatrics International, 68(1). https://doi.org/10.1111/ped.70529
Vancouver
Tasaka K, Kawaguchi K, Hirose A, Gohda Y, Nakano R, Fukumoto K, et al. Sirolimus and Staged OK ‐432 Sclerotherapy for Airway‐Compromising Cervicofacial Lymphatic Malformation in a Neonate. Pediatrics International. 2026;68(1). doi:10.1111/ped.70529
BibTeX
@article{Tasaka2026,
author = {Tasaka, Keiji and Kawaguchi, Koji and Hirose, Akira and Gohda, Yousuke and Nakano, Reiji and Fukumoto, Koji and Watanabe, Kenichiro},
title = {Sirolimus and Staged OK ‐432 Sclerotherapy for Airway‐Compromising Cervicofacial Lymphatic Malformation in a Neonate},
journal = {Pediatrics International},
year = {2026},
volume = {68},
number = {1},
doi = {10.1111/ped.70529}
}
EUVIMED